News
For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Bronchitol Approved by NICE in UK
Pharmaceutical company Pharmaxis (ASX: PXS) is pleased to announce that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has issued a positive recommendation in its Final Appraisal Determination for Bronchitol®, clearing the way for reimbursement by the National Health Service.
Read full media release - pdf
Presentation of Data at the North American Cystic Fibrosis Conference
Pharmaceutical company Pharmaxis (ASX: PXS) is pleased to announce that Bronchitol® is the subject of three presentations at the 26th annual North American Cystic Fibrosis Conference to be held in Orlando, Florida from October 10th – 13th. These presentations focus on new analyses of patient subgroups in the Phase 3 clinical trials.
The abstracts are available on the NACF conference website at: https://www.nacfconference.org/
Read full media release - pdf